FindTrial
Sign In

Multicenter Prospective Study on the Perioperative and Long-Term Efficacy and Safety of Robot-Assisted Thoracoscopic Surgery versus Video-Assisted Thoracoscopic Surgery for Non-Small Cell Lung Cancer

Multicenter Prospective Study on the Perioperative and Long-Term Efficacy and Safety of Robot-Assisted Thoracoscopic Surgery versus Video-Assisted Thoracoscopic Surgery for Non-Small Cell Lung Cancer

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500104439
Enrollment
Unknown
Registered
2025-06-17
Start date
2025-02-11
Completion date
Unknown
Last updated
2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

NSCLC

Interventions

video-assisted thoracic surgery (VATS):None
robot-assisted thoracic surgery group [(RATS):none

Sponsors

Beijing Cancer Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.Patients aged 20–80 years with clinically diagnosed or preoperatively pathologically confirmed solitary non-small cell lung cancer (NSCLC), classified as clinical stage I-IIIA, and with an ECOG PS score of 0–1. 2.Patients with postoperatively pathologically confirmed NSCLC, classified as pathological stage pI-IIIA. 3.Patients scheduled to undergo video-assisted thoracoscopic surgery (VATS) or robot-assisted thoracoscopic surgery (RATS) for anatomic lobectomy, segmentectomy, and mediastinal lymph node dissection (systematic or limited).

Exclusion criteria

Exclusion criteria: 1.Patients with postoperatively confirmed non-small cell lung cancer (NSCLC) exclusion (i.e., pathologically confirmed diagnosis other than NSCLC). 2.Patients with a history of prior thoracic surgery or malignant tumors. 3.Patients who underwent wedge resection, pneumonectomy, combined lobectomy, or chest wall resection with reconstruction. 4.Patients requiring intraoperative conversion from robot-assisted thoracoscopic surgery (RATS) to video-assisted thoracoscopic surgery (VATS) during Da Vinci robotic procedures. 5.Patients who refused to sign informed consent.

Design outcomes

Primary

MeasureTime frame
disease-free survival;—

Secondary

MeasureTime frame
Operative duration;Intraoperative blood loss;Conversion to thoracotomy rate;30-day mortality rate;24-hour postoperative drainage volume;Chest tube duration;Postoperative hospital stay;Pre-reimbursement hospitalization costs;Tumor resection rate;Number of lymph node stations sampled and total lymph nodes harvested;Cardiopulmonary complications;Chylothorax;Prolonged air leak;Pain score;overall survival;—

Countries

China

Contacts

Public ContactShaohua Ma

Beijing Cancer Hospital

2411110740@stu.pku.edu.cn+86 185 6041 2458

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026